levetiracetam

Generic: levetiracetam

Labeler: prasco laboratories
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name levetiracetam
Generic Name levetiracetam
Labeler prasco laboratories
Dosage Form TABLET, FOR SUSPENSION
Routes
ORAL
Active Ingredients

levetiracetam 250 mg/1

Manufacturer
Prasco Laboratories

Identifiers & Regulatory

Product NDC 66993-100
Product ID 66993-100_265f6517-11c1-4af8-9871-ef7fdde464e6
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA207958
Listing Expiration 2027-12-31
Marketing Start 2025-01-20

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 66993100
Hyphenated Format 66993-100

Supplemental Identifiers

RxCUI
1736045 1736048
UNII
44YRR34555
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name levetiracetam (source: ndc)
Generic Name levetiracetam (source: ndc)
Application Number NDA207958 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 6 BLISTER PACK in 1 CARTON (66993-100-06) / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (66993-100-51)
  • 60 BLISTER PACK in 1 CARTON (66993-100-60) / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (66993-100-51)
source: ndc

Packages (2)

66993-100-06 6 BLISTER PACK in 1 CARTON (66993-100-06) / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (66993-100-51) 66993-100-60 60 BLISTER PACK in 1 CARTON (66993-100-60) / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (66993-100-51)

Ingredients (1)

levetiracetam (250 mg/1)

Linked Drug Pages (1)

Levetiracetam ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "265f6517-11c1-4af8-9871-ef7fdde464e6", "openfda": {"nui": ["N0000008486"], "unii": ["44YRR34555"], "rxcui": ["1736045", "1736048"], "spl_set_id": ["dd175fa3-1d7a-4542-affd-988ac5bba1db"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Prasco Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 BLISTER PACK in 1 CARTON (66993-100-06)  / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (66993-100-51)", "package_ndc": "66993-100-06", "marketing_start_date": "20250120"}, {"sample": false, "description": "60 BLISTER PACK in 1 CARTON (66993-100-60)  / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (66993-100-51)", "package_ndc": "66993-100-60", "marketing_start_date": "20260116"}], "brand_name": "Levetiracetam", "product_id": "66993-100_265f6517-11c1-4af8-9871-ef7fdde464e6", "dosage_form": "TABLET, FOR SUSPENSION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "66993-100", "generic_name": "levetiracetam", "labeler_name": "Prasco Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "250 mg/1"}], "application_number": "NDA207958", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20250120", "listing_expiration_date": "20271231"}